March 25, 2020 / 12:25 PM / 10 days ago

BRIEF-OPKO Health Reports Interim Results For Two Ongoing Rayaldee Studies

March 25 (Reuters) - OPKO Health Inc:

* OPKO HEALTH REPORTS INTERIM RESULTS FOR TWO ONGOING RAYALDEE STUDIES

* OPKO HEALTH INC - PHASE 4 HEAD-TO-HEAD STUDY IN PATIENTS WITH STAGE 3 OR 4 CHRONIC KIDNEY DISEASE

* OPKO HEALTH INC - PHASE 2 TRIAL IN PATIENTS WITH STAGE 5 CHRONIC KIDNEY DISEASE ON DIALYSIS

* OPKO HEALTH - FINAL RESULTS FROM ONGOING PHASE 4 TRIAL FOR CHRONIC KIDNEY DISEASE TREATMENT ARE EXPECTED IN SECOND HALF OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below